Health Care: Drugs

Pacific Biosciences of California Inc (PACB: NASDAQ)

$5.78 -0.08 | -1.37%
09/02/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 28.18M 25.98M 33.86M 1.67M
Cost of Sales 15.52M 18.39M 15.03M 0.00
Gross Operating Profit 12.66M 7.59M 18.84M 1.67M
Selling, General, and Administrative Expenses 38.74M 47.66M 46.71M 30.09M
Research & Development 45.22M 47.62M 76.08M 111.82M
Operating Income before D & A (EBITDA) -71.30M -87.69M -103.95M -140.23M
Depreciation & Amortization 6.24M 6.65M 5.80M 5.16M
Interest Income 0.00 0.00 0.00 172.00K
Other Income - Net 728.00K -127.00K 368.00K -104.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -76.82M -94.46M -109.39M -145.33M
Interest Expense 2.48M 0.00 0.00 0.00
Pre-Tax Income -79.29M -94.46M -109.39M -145.33M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -79.29M -94.46M -109.39M -140.17M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -79.29M -94.46M -109.39M -140.17M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -79.29M -94.46M -109.39M -140.17M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-79.29M -94.46M -109.39M -140.17M
Preferred Dividends
Net Income Available To Common -79.29M -94.46M -109.39M -140.17M
Basic EPS from Continuing Ops. -1.26 -1.69 -2.03 -14.10
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.26 -1.69 -2.03 -14.10
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.26 -1.69 -2.03 -14.10
Basic Normalized Net Income/Share -1.26 -1.69 -2.03 -14.10
EPS fr Continuing Ops. -1.26 -1.69 -2.03 -14.10
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.26 -1.69 -2.03 -14.10
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.26 -1.69 -2.03 -14.10
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.26 -1.69 -2.03 -14.10
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with PACB

Latest PACB Headlines from TheStreet

More Financial News for PACB

Press Releases for PACB

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter